Real World Effectiveness and Safety of Ticagrelor and Prasugrel as Compared With Clopidogrel Are Inconsistent With the Findings From Clinical Trials

被引:0
|
作者
Yuan, Zhong
Plotnikov, Alexei N.
Weaver, James
Londhe, Ajit
Barnathan, Elliot
Strony, John
机构
关键词
Myocardial infarction; Ischemic stroke; Acute coronary syndromes; Pacemaker; artificial;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
15443
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Patients in Clinical Trials on COPD Triple Therapy Compared to Real World Populations
    Buhl, R.
    Criee, C.
    Kardos, P.
    Berschneider, K.
    Obermoser, V.
    Vogelmeier, C.
    Worth, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [42] Patients in clinical trials on COPD triple therapy compared to real world populations
    Kardos, P.
    Buhl, R.
    Criee, C. P.
    Obermoser, V
    Berschneider, K.
    Vogelmeier, C.
    Worth, H.
    PNEUMOLOGIE, 2020, 74 : S68 - S68
  • [43] Interpretation Of Safety Findings In Clinical Effectiveness Trials: Insights From The Salford Lung Study (sls COPD)
    Collier, S. D.
    Harvey, C.
    Bakerly, N. D.
    New, J. P.
    Woodcock, A. A.
    Vestbo, J.
    Gibson, J.
    Cardwell, G.
    El Khenini, H. F.
    Williams, C.
    Leather, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [44] Deferasirox and children: From clinical trials to the real world
    Origa, Raffaella
    Zappu, Antonietta
    Foschini, Maria Loreta
    Leoni, Giovanbattista
    Morittu, Maddalena
    Moi, Paolo
    Corpino, Mara
    Dessi, Carlo
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (06) : E304 - E305
  • [45] Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor
    Schilling, Uta
    Dingemanse, Jasper
    Dobrow, Michael
    Baumann, Martine
    Riederer, Markus A.
    Juif, Pierre-Eric
    Ufer, Mike
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (06) : 755 - 766
  • [46] Effectiveness and safety of secukinumab treatment in real-world clinical settings in European countries confirms its efficacy and safety from clinical trials: Data from an interim analysis of SERENA study
    Augustin, Matthias
    von Kiedrowski, Ralph
    Rigopoulos, Dimitris
    Sator, Paul-Gunther
    Orsenigo, Roberto
    Veit, Justyna
    Aassi, Maher
    Jagiello, Piotr
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB50 - AB50
  • [47] Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice
    Amin, Moein
    Harvey, Tucker
    Pineda, Dan Michael
    Tai, Ming-Hui
    Shao, Qiujun
    Brown, Brandon
    Gadkari, Abhijit
    Moss, Brandon
    Conway, Devon S.
    Hersh, Carrie M.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2025,
  • [48] A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis
    Yiu, Z. Z. N.
    Mason, K. J.
    Barker, J. N. W. N.
    Hampton, P. J.
    McElhone, K.
    Smith, C. H.
    Warren, R. B.
    Griffiths, C. E. M.
    Lunt, M.
    Burden, A. D.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (06) : 1265 - 1271
  • [49] Effectiveness and safety profile of leflunomide in rheumatoid arthritis:: actual practice compared with clinical trials
    Martin, K
    Bentaberry, F
    Dumoulin, C
    Dehais, J
    Haramburu, F
    Bégaud, B
    Schaeverbeke, T
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (01) : 80 - 84
  • [50] Effectiveness in a Real-World Observation Confirms Efficacy of Controlled Clinical Trials
    Kappetein, Arie Pieter
    Vahanian, Alec
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (04) : 451 - 452